investments « AGORACOM Small-cap Investor Relations Blog

Posts Tagged ‘investments’

Loop Insights $MTRX.ca Signs Agreement With #NCAA DIV. 1 SCHOOL – University Of Houston Athletics To Implement Contactless Platform For Tracing And Cashless Commerce $QUIS.ca $MCLD.ca $NXO.ca

Posted by AGORACOM-JC at 7:09 AM on Wednesday, September 16th, 2020

Announces the signing of an agreement with the University of Houston Athletics to implement Loop’s contactless, artificial intelligence marketing solutions
Will provide personalized promotions and targeted engagement, as well as, Loop’s leading contact tracing solutions for the purposes of supporting resumption plans that provide a safe environment for fans and guests attending Houston football games at TDECU Stadium
Loop’s e-commerce solutions will be integrated within the platform to provide fans with an ability to purchase event tickets, concessions, merchandise products, and parking services without having to use physical cash

VANCOUVER, BC, Sept. 16, 2020 – Loop Insights Inc. (MTRX: TSXV) (the “Company” or “Loop”), a provider of contactless solutions and artificial intelligence (“AI”) to drive automated marketing, contact tracing, and contactless solutions to the brick and mortar space, is pleased to announce the signing of an agreement with the University of Houston Athletics (“UH”) to implement Loop’s contactless, artificial intelligence marketing solutions to provide personalized promotions and targeted engagement, as well as, Loop’s leading contact tracing solutions for the purposes of supporting resumption plans that provide a safe environment for fans and guests attending Houston football games at TDECU Stadium.

The University of Houston is a public research university in Houston, Texas, and the main institution of the University of Houston System. Founded in 1927, UH is the third-largest university in Texas, with over 47,000 students.

LOOP SOLUTION TO PROVIDE HOUSTON ATHLETICS WITH ABILITY TO ACHIEVE CASHLESS AND CONTACTLESS GOALS

Given the health risks related to COVID-19 and the uncertainty about the duration of its impact on society, UH Athletics will be working with Loop in the development and implementation of a contactless and cashless solution for fans and guests attending events at TDECU Stadium. Loop’s services will help Houston Athletics deliver on this goal by first implementing its contact tracing solution, which will provide Houston football fans and guests safe and secure access when attending events.

Secondly, Loop’s e-commerce solutions will be integrated within the platform to provide fans with an ability to purchase event tickets, concessions, merchandise products, and parking services without having to use physical cash.

Finally, with users now using the platform to conduct their purchases and access events, Loop’s artificial intelligence marketing services will provide unmatched personalized promotions and engagement opportunities, creating a more interactive fan experience at Houston athletic events. Loop’s services and technologies will offer a more robust game day experience for all Houston football fans.

Loop Insights CEO Rob Anson stated, “Our first priority is reopening and keeping campus doors open through our proven and scalable contact tracing platform. Secondly, we want to help UH maintain and increase its revenues. We expect to generate meaningful revenue from monthly fees associated to active users on the Loop platform as well through participation in a revenue share. With our integrated product stack, UH and all of the other 356 NCAA Div.1 colleges can gain immediate access to all of Loop’s products and services and benefit from increased profitability through streamlined operational efficiencies. We intend to deliver a future proof campus experience, so the next wave of Covid-19 does not close their doors for good. Loop is the complete solution.”

University of Houston‘s Deputy Athletic Director David Tagliarino stated, “A main goal for us is to administer enhanced safety protocols and best practices, measures that instill confidence among our fans and guests during these challenging times due to Covid-19. Loop’s solution is appealing because it also provides fully automated and personalized fan experiences with large-scale user adoption and enhanced fan engagement opportunities. In addition to improving the way we interact with fans inside and outside the stadium, Loop’s contact tracing will greatly assist our efforts in returning fans to our venues in a safe and prudent manner.”

This Press Release Is Available On The Loop Insights Verified Forum On AGORACOM For Shareholder Discussion and Q&A https://agoracom.com/ir/LoopInsights/forums/discussion

About Houston Athletics

University of Houston Athletics sponsors 17 intercollegiate sports for nearly 400 student-athletes. The department’s mission is to develop its student-athletes into champions for life and focuses daily on the success and welfare of its student-athletes. A member of the American Athletic Conference, Houston has led its league in conference championships in each of the last five seasons. For more information on UH Athletics, visit UHCougars.com.

About Loop Insights

Loop Insights Inc. is a Vancouver-based Internet of Things (“IoT”) technology company that delivers transformative artificial intelligence (“AI”) automated marketing, contact tracing, and contactless solutions to the brick and mortar space. Its unique IoT device, Fobi, enables data connectivity across online and on-premise platforms to provide real-time, detailed insights and automated, personalized engagement. Its ability to integrate seamlessly into existing infrastructure, and customize campaigns according to each vertical, creates a highly scalable solution for its prospective global clients that span industries. Loop Insights operates in the telecom, casino gaming, sports and entertainment, hospitality, and retail industries, in Canada, the US, the UK, Latin America, Australia, Japan, and Indonesia.

Forward-Looking Statements/Information:

This news release contains certain statements which constitute forward-looking statements or information. Such forward-looking statements are subject to numerous risks and uncertainties, some of which are beyond Loop’s control, including the impact of general economic conditions, industry conditions, and competition from other industry participants, stock market volatility and the ability to access sufficient capital from internal and external sources. Although Loop believes that the expectations in its forward-looking statements are reasonable, they are based on factors and assumptions concerning future events which may prove to be inaccurate. Those factors and assumptions are based upon currently available information. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors that could influence actual results or events and cause actual results or events to differ materially from those stated, anticipated or implied in the forward-looking statements. As such, readers are cautioned not to place undue reliance on the forward-looking statements, as no assurance can be provided as to future results, levels of activity or achievements. The forward-looking statements contained in this news release are made as of the date of this news release and, except as required by applicable law, Loop does not undertake any obligation to publicly update or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise. The forward-looking statements contained in this document are expressly qualified by this cautionary statement. Trading in the securities of Loop should be considered highly speculative. There can be no assurance that Loop will be able to achieve all or any of its proposed objectives.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE LOOP Insights Inc.

Tags: AI, artificial intelligence, covid19, Covid19 tracing, CSE, internet of things, investments, IOT, small cap stocks
Posted in Featured, Loop Insights Inc. | Comments Off on Loop Insights $MTRX.ca Signs Agreement With #NCAA DIV. 1 SCHOOL – University Of Houston Athletics To Implement Contactless Platform For Tracing And Cashless Commerce $QUIS.ca $MCLD.ca $NXO.ca

#IoT and Big Data: 6 Retail and Financial Services Trends to Watch Out For – SPONSOR: Loop Insights Inc. $MTRX.ca $QUIS.ca $MCLD.ca $NXO.ca

Posted by AGORACOM-JC at 2:42 PM on Friday, September 11th, 2020

SPONSOR: Loop Insights Inc. (MTRX:TSX-V) is levelling the playing field between online retail giants and brick & mortar businesses. What if you could receive the same personalization and experience you get from online shopping, but in brick and mortar stores? Loop Insights is doing just that. Brick and mortar retail isn’t going anywhere, but it does need to adapt to offer better in-store customer experiences. Loop Insights solves a significant problem for traditional retailers – big and small – who are losing customers to e-commerce retail. Learn more.

IoT and Big Data: 6 Retail and Financial Services Trends to Watch Out For

IoT Will Revolutionize Point of Sale (POS) Payments
The POS industry is projected to be worth an estimated $109 billion by 2025, and IoT technology will play no small role in making this happen: while the best POS systems available today have a number of impressive features, POS technology will only evolve.
The rise of smart POS systems will result in the widespread adoption of biometric POS, the rise of mobile POS payments, digital product tracking that eliminates queues and makes remote payments easy, and much more

More importantly, IoT and big data enable the effective storage, processing, and transmission of data in a way that is more secure while providing advanced analytics that thoroughly monitors and notifies you of potential data breaches. This will make POS systems more secure and reliable further enhancing the retail industry.Bamidele Onibalusi – September 3, 2020

While the impact of the IoT industry in the past few years has been nothing short of impressive, the disruption this technology will bring to the financial services market will be just as impactful.

According to a research study by Markets and Markets, the global banking and financial services IoT market is expected to grow from $249.5 million to $2.03 billion by 2023. That’s an eight-fold growth in just five years or a CAGR of approximately 52 percent. IoT technology in the retail industry is also expected to grow to $35 billion by the end of this year.While the impact of the IoT industry in the past few years has been nothing short of impressive, the disruption this technology will bring to the financial services market will be just as impressive. Click To Tweet

Below are six key trends that will drive the growth of IoT and big data in finance and retail.

1. IoT Will Make Risk Assessment Seamless and Easy

One area where IoT technology will be disruptive in the near future is that of risk assessment. Think about how risk assessment currently works in the financial services sector. It’s a very subjective process similar to the one that triggered the 2008 Great Recession. Now imagine a future that allows for smart risk assessment by using big data and IoT technologies.

First, IoT and big data will make it easy to acquire vast amounts of data that are used to determine a customers’ risk status. This data can then be smartly analyzed in a way that the risk profile of any company or individual becomes convenient and easy. The data can also be used to forecast future risks for individuals and organizations.

2. IoT Will Enhance and Automate Security in Financial Institutions

IoT technology will contribute to a more secure future, particularly in the retail and financial services industry.

Connected smart cameras and motion sensors are just two of the smart technologies financial institutions and retailers can deploy for better security. These technologies will not only automatically react to intrusions by thieves and unauthorized third parties (by shutting down certain systems, locking down the premises so that the intruder is unable to leave, and immediately notifying you and providing an abundance of information that you can act upon), but it will also act to protect against environmental hazards that can pose security threats or result in damage.

3. IoT Will Revolutionize Point of Sale (POS) Payments

The POS industry is projected to be worth an estimated $109 billion by 2025, and IoT technology will play no small role in making this happen: while the best POS systems available today have a number of impressive features, POS technology will only evolve. The rise of smart POS systems will result in the widespread adoption of biometric POS, the rise of mobile POS payments, digital product tracking that eliminates queues and makes remote payments easy, and much more.

4. More Efficient Inventory Management

Retailers very well know the cost of an inefficient inventory management system. Data shows that U.S. retailers lose an estimated $45 billion annually due to not having the required inventory in stock and a whopping $224 billion due to having excess inventory.

IoT and big data will be able to fix inventory woes. Automated IoT inventory management systems that make real-time tracking of inventory easy at the point of sale will be in every retail store sooner rather than later. The inventory system automatically generates data to show currently in-stock items and effectively analyzes this data to predict future inventory requirements.

5. Smart Asset Movement and Monitoring

Asset monitoring is currently partially automated due to the use of computers and technology, but still involves a lot of manual process and checks. IoT and big data will change this.

First, IoT will automate the process of gathering data and real-time information that can be automatically analyzed to understand the current state of things and predict the future. IoT also makes effective use of sensors attached to assets to track them (paying attention to variables that include temperature, humidity, proximity, and movement) and then automatically generate useful data about these assets. This allows for enhanced real-time monitoring of the health and movement of assets.

6. Increasing Use of Wearable Tech for Financial Transactions

Smartwatches and wearable technology that automatically monitor human health and activity are increasingly prevalent. These devices provide essential information about the health of the wearer at all times. Now, think about something similar for payments: you walk into the bank and the bank’s IoT system connects to your wearable device which sends essential information about your activity to the bank. Not only does this eliminate a lot of time-wasting manual processes and improve customer satisfaction, but it also makes it easier to perform contactless transactions while at the same time ensuring optimal security.

The financial industry is already reaping the benefits of IoT and big data. As more businesses see the advantages of IoT, the adoption rate to improve outdated business practices will rapidly increase.

Source: https://www.iotforall.com/iot-and-big-data-6-retail-and-financial-services-trends-to-watch-out-for/

Tags: AI, artificial intelligence, covid19, Covid19 tracing, CSE, internet of things, investments, IOT, small cap stocks, tsx
Posted in All Recent Posts, Featured, IoT, Loop Insights Inc. | Comments Off on #IoT and Big Data: 6 Retail and Financial Services Trends to Watch Out For – SPONSOR: Loop Insights Inc. $MTRX.ca $QUIS.ca $MCLD.ca $NXO.ca

Why #AI and #IoT will play a big role in retail of tomorrow – SPONSOR: Loop Insights Inc. $MTRX.ca $QUIS.ca $MCLD.ca $NXO.ca

Posted by AGORACOM-JC at 2:53 PM on Thursday, September 10th, 2020

Why AI and IoT will play a big role in retail of tomorrow

While e-commerce’s growth has accelerated by “four to six years” according to a recent report published by Adobe indicated that on the ground retailers are now embracing digital-first approaches in order to acclimate to the new norms of social distancing and minimized contact
By enlisting artificial intelligence (AI) and Internet of Things (IoT) solutions, the retail sector is implementing new approaches to enhance customer experience, drive sales, and, most importantly, ensure the safety of employees and retailers in stores

The pandemic has left irreversible changes within the retail industry as consumer behavior during a time of limited and regulated movement evolved. A PYMNTS 2020 Remote Payments Study reported that mobile devices are the most popular device for online shopping, with up to 72% of consumers using their mobile devices to shop.

The explosion of online shopping saw an increase of 146% in online retail orders as of April 21, 2020 when compared to the same period last year. While e-commerce’s growth has accelerated by “four to six years” according to a recent report published by Adobe indicated that on the ground retailers are now embracing digital-first approaches in order to acclimate to the new norms of social distancing and minimized contact. By enlisting artificial intelligence (AI) and Internet of Things (IoT) solutions, the retail sector is implementing new approaches to enhance customer experience, drive sales, and, most importantly, ensure the safety of employees and retailers in stores.

AI

AI applications can accommodate multiple retail scenarios; AI in the retail market is set to hit US$19.9 billion by 2027, with leading brands already placing AI in storefronts.

Luxury department store Neiman Marcus makes it easier for customers to find items through visual search. The company’s Snap.find.shop. app is powered by AI, and it enables customers to seek items that match closely with photos they’ve taken.

At Macy’s, customers can seek the assistance of the company’s On Call app for a better shopping experience. Macy’s On Call app is tailored with answers for specific stores. Customers can chat with an AI-backed bot for inventory checking and directions to navigate around the store. Interestingly, the AI bot is able to detect if a customer is getting frustrated and alert a store associate for help.

These projects were already well in place before the pandemic but will play a bigger role post-COVID, serving as an example for other retailers seeking to incorporate technology. These AI-inspired solutions are customer-centric and could potentially take over the role of store associates, which helps reduce the risks for retail employees at this time.

IoT

If AI solutions are adopted for enhanced services and to ease the burden of store personnel, IoT is then famed for their data-driven approaches to turbocharge core operations in retail.

Recently, Auchan Retail Portugal, with a network of 34 supermarkets and hypermarkets across the European country, announced it would deploy a fleet of autonomous robots for optimized shelf monitoring.

These autonomous robots will circle around the stores up to three times daily to capture photos of every shelf and aisle. The captured photos are then digitized at scale with computer vision and IoT, and then converted into reports with actionable insights for store staff to act upon. The reports delivered through a mobile app will boost store employees’ efficiency in managing, prioritizing, and resolving shelf issues.Andre Vieira, Digital Director at Auchan Retail Portugal, noted that “innovation, through the search for digital strategies, focused on people and improving customer service is one of Auchan’s great bets. With the introduction of autonomous robots, Auchan wants to improve productivity in stores, and optimize the supply chain, freeing employees to focus 100% on the mission of providing a better customer experience.”

Source: https://techhq.com/2020/08/why-ai-and-iot-will-play-a-big-role-in-retail-of-tomorrow/

Tags: AI, artificial intelligence, covid19, Covid19 tracing, CSE, internet of things, investments, IOT, small cap stocks, tsx, tsx-v
Posted in Featured, IoT, Loop Insights Inc. | Comments Off on Why #AI and #IoT will play a big role in retail of tomorrow – SPONSOR: Loop Insights Inc. $MTRX.ca $QUIS.ca $MCLD.ca $NXO.ca

DataMetrex $DM.ca Secures Contract with 7-Eleven

Posted by AGORACOM-JC at 8:14 AM on Thursday, September 10th, 2020

Announced that it has entered into a sales agreement with 7-Eleven Korea for Robotic Process Automation infrastructure.
RPA is the technology that enables anyone to configure computer software today, or a “robot” to replicate and incorporate the actions of a person working within digital systems to conduct a business process
Global RPA market size is expected to reach $7.2 billion by 2025, rising at a market growth of 32.6% CAGR during the forecast period

Toronto, Ontario–(September 10, 2020) – Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC Pink: DTMXF) (the “Company” or “Datametrex“) is pleased to announce that it has entered into a sales agreement with 7-Eleven Korea for Robotic Process Automation (“RPA”) infrastructure.

The global RPA market size is expected to reach $7.2 billion by 2025, rising at a market growth of 32.6% CAGR during the forecast period. RPA is the technology that enables anyone to configure computer software today, or a “robot” to replicate and incorporate the actions of a person working within digital systems to conduct a business process. An increased demand for business process automation (“BPA”) is expected to be the main growth driver through the use of Artificial Intelligence (“AI”) and RPA.[1]

7-Eleven is a international chain of convenience stores founded in 1927 in the United States with over 70,000 stores located around the globe. 7-Eleven has a legacy of innovation and delivering “what the customers want, when and where they want it.”

Datametrex is working closely with clients to power it through their digital initiatives and improve their delivery on innovation as they continue the pursuit of catering to a modern, digital-savvy generation of shoppers.

“At Datametrex, we continue our efforts to facilitate ground-breaking technologies to companies across the globe. Our technology is proven to be valuable to make sense of the data beyond complicated spreadsheets.” said Marshall Gunter, CEO of Datametrex. “We pride ourselves in providing tools that our clients can use to visualize their customer and stakeholder data. Through predictive analysis they can support their decision making, mitigate risk, and improve their bottom line.”

Investor Webinar

Datametrex also announces that senior management will be hosting an investor update webinar on Tuesday, September 15, 2020, at 1:00 p.m. ET to discuss the Company’s Second Quarter 2020 results, developments and contracts on the Artificial Intelligence technologies and COVID-19 test kits.

Webinar Details:

Date: Tuesday, September 15, 2020

Time: 1:00 p.m. ET

Registration Link: https://us02web.zoom.us/webinar/register/WN_FZc3a5nlQiKlsTEq5bqFfQ?t=1599612433950

Datametrex plans to answer questions previously sent to [email protected] and during the webinar, at management’s discretion and subject to time constraints.

About Datametrex

Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com.

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy. Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.____________________________________

[1] Source: Global Robotic Process Automation Market By Component By Organization Size By Deployment Type By End User By Region, Industry Analysis and Forecast, 2019 – 2025NOT FOR DISTRIBUTION TO U.S. NEWS SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

Tags: 1drop Inc., 7-Eleven, covid19, CSE, datametrex, investments, Lotte, Lotte Home Shopping, PCL, small cap stocks, stocks, tsx
Posted in Datametrex AI Limited, Featured | Comments Off on DataMetrex $DM.ca Secures Contract with 7-Eleven

Empower Clinics $CBDT.ca Expands COVID-19 Testing Programs by Commencing RT-PCR Testing $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 6:56 AM on Thursday, September 10th, 2020

Commenced COVID-19 reverse transcription polymerase chain reaction (RT-PCR), testing through its Sun Valley Health operations in Arizona, using RT-PCR test kits and laboratory test processing by Kai Medical Laboratory in Dallas, TX., the recently announced proposed acquisition target by Empower
programs are part of a “Back to Work” and “Back to School” initiative supported by a variety of outbound marketing campaigns including new Facebook ads, text message & email campaigns and outbound call-center campaigns targeting businesses, universities & colleges, sports teams or organizations where effective social distancing could be difficult.

VANCOUVER BC / September 10, 2020 / EMPOWER CLINICS INC. (CSE:CBDT)(Frankfurt:8EC)(OTCQB:EPWCF) (“Empower” or the “Company“) today announces it has commenced COVID-19 reverse transcription polymerase chain reaction (RT-PCR), testing through its Sun Valley Health operations in Arizona, using RT-PCR test kits and laboratory test processing by Kai Medical Laboratory in Dallas, TX., the recently announced proposed acquisition target by Empower.

The programs are part of a “Back to Work” and “Back to School” initiative supported by a variety of outbound marketing campaigns including new Facebook ads, text message & email campaigns and outbound call-center campaigns targeting businesses, universities & colleges, sports teams or organizations where effective social distancing could be difficult.

RT-PCR Testing can be booked via: https://www.sunvalleyhealth.com/covid-19-test-book-now/

Currently Kai Medical Laboratory has the capacity to complete in excess of 2,000 RT-PCR tests in one eight-hour shift by utilizing its Thermo Fisher QuantStudio 12k Flex testing machine.

“Launching our RT-PCR testing programs utilizing the capability of Kai Medical Labs gives us the ability to access massive testing volume not only in Arizona, but nationwide in the U.S.” said Steven McAuley, Empower’s Chairman & CEO. “Our team at Sun Valley Health has created numerous strategic marketing campaigns to drive awareness and testing volume, leveraging our supply chain improvements with increased profit margins.”

Many schools and universities are now requiring students and teachers to provide RT-PCR testing results prior to returning to campus. Our nasal or throat swab RT-PCR testing program allow students and teachers to quickly be tested and receive results from a Clinical Laboratory Improvement Amendments (CLIA), accredited laboratory in only 24 – 48 hours.

Businesses need a stable workforce, and must be quick to isolate employees with any symptoms. Our RT-PCR testing allows employees to be tested quickly and receive results within 24 – 48 hours, giving the employee and the employer the opportunity to activate non-contagious employees and safely return to work!

Travelers are also discovering demands to get a RT-PCR test and provide the result upon check-in at the airport. The reports are required to be no more than 3 days old. Our testing program provides accurate results within 24-48 hours, giving the patient a document that can make the difference in being able to travel.

https://www.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/k-12-testing.html

https://www.wsj.com/articles/universities-plan-robust-covid-19-testing-for-returning-students-11594812937

An RT-PCR assay is a viral molecular test to detect active infection directly in a patient’s RNA genetic sequence. An RT-PCR swab test is considered the gold-standard for testing & diagnosing active viral infections and should be used for anyone who has symptoms or known exposure to COVID-19. These tests are renowned for high sensitivity and high specificity.

(CLIA) The Clinical Laboratory Improvement Amendments regulate laboratory testing and require clinical laboratories to be certified by the Center for Medicare and Medicaid Services (CMS) before they can accept human samples for diagnostic testing.

USA COVID-19 Data as at September 9, 2020
TOTAL CASES: 6,310,663
TOTAL DEATHS: 189,147
CASES IN LAST 7 DAYS: 262,971

ARIZONA as at September 9, 2020
CONFIRMED CASES: 204,239
PROBABLE CASES: 1,806
TOTAL CASES: 206,045
CASES IN LAST 7 DAYS: 3,703
CASES/100K: 2,873
DEATHS/100K: 72

TEXAS as at September 9, 2020
TOTAL CASES: 641,791
CASES IN LAST 7 DAYS: 24,458
CASES/100K: 2,236
DEATHS/100K: 47

ABOUT EMPOWER

Empower is a vertically integrated health & wellness company with a network of corporate and franchised health & wellness clinics in the U.S. The Company is focused on helping patients improve and protect their health, through innovative physician recommended treatment options. The Company has launched Dosed Wellness Ltd. to connect its significant data, to the potential of the efficacy of alternative treatment options related to hemp-derived cannabidiol (CBD) therapies, psilocybin and other psychedelic plant-based treatment options. The Company provides COVID-19 testing services to consumers and businesses as part of a four-phased nationwide testing initiative.

ABOUT Kai Medical Laboratory

Kai Medical Laboratory is a high-complexity CLIA and COLA accredited Laboratory that provides reliable and accurate testing solutions to hospitals, medical clinics, pharmacies, and employer groups. Kai Medical Laboratory offers a wide array of testing services ranging from hematology to hormone testing, endocrinology, toxicology, and immunology. These tests are done under the supervision of its well-qualified and highly experienced scientists, medical professionals, and pharmacists. https://www.kaimedicallaboratory.com

ON BEHALF OF THE BOARD OF DIRECTORS:

Steven McAuley
Chief Executive Officer

CONTACTS:

Investors: Dustin Klein
Director
[email protected]
720-352-1398

Investors: Steven McAuley
CEO
[email protected]
604-789-2146

DISCLAIMER FOR FORWARD-LOOKING STATEMENTS

This news release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release.Forward-looking statements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include, but are not limited to, statements regarding: the expected benefits to the Company and its shareholders as a result of the proposed acquisition of Sun Valley; the proposed transaction terms; the expected number of clinics and patients following the closing; the future potential success of Sun Valley’s franchise model; the anticipated date of closing of the acquisition and the occurrence thereof; and that the Company will be positioned to be a market-leading service provider for complex patient requirements in 2019 and beyond. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including: that the Kai Medical Laboratory acquisition may not be completed on the terms expected or at all; that the Company’s products may not work as expected; that the Company may not be able to expand COVID-19 testing; that legislative changes may have an adverse affect on the Company’s business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with the proposed transaction; and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.

SOURCE: Empower Clinics Inc.

Tags: CBD, covid19, CSE, Dosed Movie, Dosed Wellness, Hemp, investments, Kai Medical Laboratory, small cap, small cap stocks, stocks
Posted in Empower Clinics Inc., Featured | Comments Off on Empower Clinics $CBDT.ca Expands COVID-19 Testing Programs by Commencing RT-PCR Testing $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca

EVENT: You’re invited to Datametrex $DM.ca Investor Webinar on September 15th @ 1 PM EST.

Posted by AGORACOM-JC at 1:18 PM on Wednesday, September 9th, 2020

You’re invited to our Investor Webinar on September 15th @ 1 PM EST. We will be discussing the Q2 financials, and the following topics: COVID-19 Testing and AI technology.

Please click the link below to register:

https://us02web.zoom.us/webinar/register/WN_FZc3a5nlQiKlsTEq5bqFfQ

Tags: 1drop Inc., covid19, CSE, datametrex, investments, Lotte, Lotte Home Shopping, PCL, small cap stocks, stocks, tsx
Posted in Datametrex AI Limited, Featured | Comments Off on EVENT: You’re invited to Datametrex $DM.ca Investor Webinar on September 15th @ 1 PM EST.

Datametrex $DM.ca Receives Largest #COVID19 Test Kits Order to Date for $1.6M From a Canadian Mining Company

Posted by AGORACOM-JC at 10:45 AM on Thursday, September 3rd, 2020

http://www.smallcapepicenter.com/DM%20square.png

Announced the largest purchase order to date from a Canadian Mining Company with operations worldwide
P.O. is for 50,000 1drop Inc.
P.O. is for their Peru and Surinam mining operations.
Total gross sales amount is approximately $1.6M CAD, excluding shipping and courier fees
COVID-19 test kits manufactured by 1drop Inc.

TORONTO, Sept. 03, 2020 — Datametrex AI Limited (the “Company” or “Datametrex“) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce the largest purchase order (the “P.O.”) to date from a Canadian Mining Company (the “Purchaser”) with operations worldwide. The P.O. is for 50,000 1drop Inc. This P.O. is for their Peru and Surinam mining operations. The total gross sales amount is approximately $1.6M CAD, excluding shipping and courier fees. The P.O. is for 50,000 COVID-19 test kits manufactured by 1drop Inc.

Under the terms of the P.O., Datametrex will provide the Purchaser with an initial 50,000 units of the COVID-19 qPCR Detection Kits manufactured by 1drop Inc. (“1drop”), 50,000 Universal Transport Medium (UTM®), Sterile Swabs with 16x100mm and Skirted Tubes. The Company is also shipping two (2) Real-Time Polymerase Chain Reaction Detection System (“PCR”) machines along with software to ensure optimal assay performance of the samples, and 50,000 RNA extraction kits.

Datametrex anticipates that it has little or no upfront costs associated with the sale of these test kits. All of the items are shipped directly from manufacturers to the purchaser’s mine operating sites in Peru and Surinam.

A publicly available survey provided by Statista with sources from Johns Hopkins University (CSSE), World Bank, and Insee, states that Peru is the most impacted country with the most deaths per million (908.8 deaths per million, at the date of this news release – source: https://bit.ly/3bikTRo). Also, Peru is the number two copper producer in the world and with the mining stoppages from the COVID-19 pandemic, combined with operational issues, mine output has declined by 23% over the first five months, with April and May registering declines of 33% and 41%, respectively, as stated by the International Copper Study Group recently reported – source: https://bit.ly/3i64Qc5

“Datametrex is glad to be able to help companies in Peru deal with this urgent situation. Assisting with the implementation of test kits is a fundamental response to the pandemic, and those mining companies that have been able to test more comprehensively have had greater success dealing with the pandemic,” says Marshall Gunter, CEO of the Company. “The reasoning is simple: An individual who tests positive can be isolated until they recover, and their contacts may be traced and similarly tested and isolated, effectively reducing the rate of transmission. We hope our technologies, combined with everyone’s efforts, contribute to the mitigation of the spread in operational mining sites.”

About Datametrex

Datametrex AI Limited is a technology-focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational Health and Safety goals with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain.

Additional information on Datametrex is available at www.datametrex.com

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Forward-Looking Statements

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Tags: 1drop Inc., covid19, CSE, datametrex, investments, Lotte, Lotte Home Shopping, PCL, small cap stocks, stocks, tsx, tsx-v
Posted in Datametrex AI Limited, Featured | Comments Off on Datametrex $DM.ca Receives Largest #COVID19 Test Kits Order to Date for $1.6M From a Canadian Mining Company

Datametrex $DM.ca Applies to Health Canada for 5 Minute Fast Antigen Kit

Posted by AGORACOM-JC at 8:18 AM on Tuesday, September 1st, 2020

Announced that the Company has submitted a Medical Devices Interim Order Request Form to approve PCL, Inc.’s COV05 COVID19 Rapid Antigen Detection Kits to Health Canada
Application is made under IO Respecting the Importation and Sale of Medical Devices for Use in Relation to COVID-19 pursuant to subsection 30.1(1) of the Food and Drugs Act signed by the Minister of Health on August 24, 2020, for PCLCOV05 COVID19 Rapid Antigen Detection Kits.

TORONTO, Sept. 01, 2020 – Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G, OTC: DTMXF ) is pleased to announce that the Company has submitted a Medical Devices Interim Order (“IO”) Request Form to approve PCL, Inc.’s (“PCL”) COV05 COVID19 Rapid Antigen Detection Kits to Health Canada.

This application is made under IO Respecting the Importation and Sale of Medical Devices for Use in Relation to COVID-19 pursuant to subsection 30.1(1) of the Food and Drugs Act signed by the Minister of Health on August 24, 2020, for PCLCOV05 COVID19 Rapid Antigen Detection Kits. This IO will allow Health Canada to issue expedited review and approval for the sale of these test kits in Canada.

The Company has represented to Health Canada that it will be able to provide a minimum first order of 200,000, followed by an additional 200,000 units on a weekly basis. Any purchase of the test kits by the Canadian government is conditional on prior receipt of Health Canada approval.

These test kits are suitable for point of care tests. No extra equipment is needed. They are simple to use and results are available in 10 minutes.

“According to the manufacturer, PCL, this test can detect antigens of COVID-19 from a swab in the nose and throat to provide results in 5-10 minutes with over 86% accuracy,” said Marshall Gunter, CEO of Datametrex. “These almost-instant kits can be easily used at home. With the rise of cases in the United States and throughout the world, we at Datametrex believe it is critical to test and protect.”

View the PCL Antigen test manual video by clicking the link: PCL COVID-19 ANTIBODY TEST – COV0

According to PCL the clinical sensitivity (confirmed the actual positive of the approved person where approved person tested positive with a PCR nucleic test) is 86.49% and the clinical specificity (confirmed the actual negative of the negative person where the negative person tested negative with a PCR nucleic test) is 97.87%*. Early detection using rapid tests will also provide further protection to Canada’s front-line workers, especially health care professionals.

The following certifications have been awarded to these PCL Antigen Test Kits: CE Certificate, Korea KPMG, FIND Listed, UNGM Supplier. Countries includes the EU, 2 countries in the Middle East- Qatar and UAE, India, Russia, 3 countries in Latin America- Guatemala, Ecuador, and Colombia.

The PCL Inc Antigen Detection kit has the CE Certificate meaning that the manufacturer and products have met EU declaration of standards for health, safety, and environmental protection, allowing this product to be sold within the 22 countries in the European Economic Area.

Health Canada must approve these COVID-19 test kits before they can be used in Canada. The Company plans to sell these kits in all countries where the kits have been approved for sale. Datametrex anticipates that it will have little or no upfront costs associated with importing these test kits. Assuming Health Canada approves the test kits and they are subsequently purchased by the Canadian government, manufacturer will ship the test kits directly to the Canadian government or hospitals, and Datametrex will not be involved in the shipping, warehousing or distribution process.

* Clinical Accuracy

The clinical performance of the PCL COVID-19 Ag Rapid FIA was evaluated in two different institutions compared to RT-PCR positive cases. Positive percent is 86.49% (95% CI: 70.43-94.92%) and negative percent agreement is 97.87% (95% CI: 87.28%-99.89%) in the PCL COVID-19 Ag Ripid FIA.

COVID-19 Ag Ripid FIA.	RT – PCR	PPA (%)	NPA (%)
POS	NEG
Site 1	POS	20	0	100.00	96.00
NEG	0	20
Total	20	20
Site 2	POS	12	1	70.59	100.00
NEG	5	26
Total	17	27
Total	POS	32	1	86.49	97.87
NEG	5	46
Total	37	47

About Datametrex

Datametrex AI Limited is a technology-focused with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com.

For further information, please contact:
Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not historical may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the time such forward-looking information is made. Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Tags: covid19, CSE, datametrex, investments, Lotte, Lotte Home Shopping, PCL
Posted in Datametrex AI Limited, Featured | Comments Off on Datametrex $DM.ca Applies to Health Canada for 5 Minute Fast Antigen Kit

Empower Clinics $CBDT.ca Announces Acquisition of Medical Diagnostics Laboratory $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 7:06 AM on Tuesday, September 1st, 2020

Empower intends to acquire Kai Medical Laboratory, a state-of-the-art diagnostics laboratory located in the medical district of Dallas, TX to advance COVID-19 national testing programs

Entered into a non-binding term sheet to acquire the business of Kai Medical Laboratory, LLC, by way of a share or asset acquisition, subject to due diligence and customary closing conditions
Kai Medical Laboratory is a high-complexity CLIA and COLA accredited Laboratory that provides reliable and accurate testing solutions to hospitals, medical clinics, pharmacies, and employer groups
Kai Medical Laboratory offers a wide array of testing services ranging from hematology to hormone testing, endocrinology, toxicology, and immunology

VANCOUVER, BC / September 1, 2020 / EMPOWER CLINICS INC. (CSE:CBDT) (Frankfurt:8EC) (OTCQB:EPWCF) (“Empower” or the “Company“) today announces it has entered into a non-binding term sheet to acquire the business of Kai Medical Laboratory, LLC (“Kai Medical Laboratory“), by way of a share or asset acquisition, subject to due diligence and customary closing conditions.

Kai Medical Laboratory has taken an active role in COVID-19 testing, battling the pandemic through RT-PCR testing and serology testing. While the RT-PCR test identifies if a patient has an active virus, the serology or antibody test detects if a patient has previously been exposed to the virus. Both of these test results are vital to managing outbreaks and the potential spread of coronavirus.

To further assist with COVID-19 testing, Kai Medical Laboratory has also developed two key programs in Texas and Arizona. The first program is a direct-to-consumer program that leverages the ability of various healthcare providers to order and administer both the RT-PCR test and the Antibody test. This increases the ability of the general population to be tested, in certain circumstances. The second is an Employer COVID-19 Compliance Program (ECCP) for business owners and employer groups to enable them to test and monitor their employees.

Texas program https://www.testtexasnow.com

Arizona program https://www.covidtest2u.com

Currently the lab has the capacity to complete in excess of 2,000 RT-PCR tests in one eight-hour shift by utilizing its Thermo Fisher QuantStudio 12k Flex testing machine. The lab also utilizes a Roche Cobas 6000 for COVID-19 Antibody testing, ensuring that Kai Medical Laboratory has the capability and capacity to serve a broad range of clients and test methods.

“Adding Kai Medical Laboratory to the Empower Clinics family enables us to dramatically expand COVID-19 testing capability and deliver phase four of our national rollout plan” said Steven McAuley, Empower’s Chairman & CEO. “Kai Medical has a newly built high-complexity lab offering a wide array of testing services, that together we will leverage to serve the massive demand for national COVID testing in the U.S. Further, as flu season arrives and a potential second-wave of COVID takes hold, the technical infrastructure of Kai Medical allows Empower to capture testing demand and the additional growth revenues associated with it.”

The driving force behind Kai Medical Laboratory’s remarkable growth and success is Yoshi Tyler. Yoshi has a passion for being an entrepreneur, and overtime, she found her true calling in healthcare. Driven by this interest, she pursued her career in the healthcare industry for more than two decades. She helmed leadership positions at a Fortune 500 pharmaceutical company for over thirteen years. These leadership experiences provided her with in-depth knowledge and industry insights that helped her to lead Kai Medical Laboratory towards growth.

The Kai Medical Laboratory team includes key roles including Principal Scientist, Director of Operations, Molecular Scientist, Quality Assurance, Lab Director and other critical roles.

“Kai Medical Laboratory is inspired by science and built on integrity. Our mission is to change healthcare through science & innovative quality care by providing value-added services, accuracy, and consistency. Our unwavering commitment to quality compliance and scientific innovation elevates Kai Medical Laboratory to a new standard in healthcare,” says Yoshi Tyler, the owner, and CEO of the company.

The proposed acquisition includes an 8,000 sq. ft. medical laboratory including covered drive up testing center, with premium testing and laboratory equipment, cash and current assets with a value in excess of $1,750,000.00 USD and a corporate office, both located in the heart of the medical district in Dallas, TX. Under the proposed terms Empower will assume a $1,200,000.00 USD Small Business Administration (SBA) equipment loan, a $150,000.00 SBA Economic Injury Disaster Loan and short-term liabilities of up to $250,000.00 at closing. In addition, Empower will issue 1,000,000 Company stock options to the Vendors, subject to the terms and conditions as set out in the Company Stock Option Plan.

Market Leading Technology Kai Medical Laboratory utilizes state-of-the-art instrumentation, preeminent testing methodologies, and laboratory services enabling high-complexity accredited laboratory testing solutions, providing some of the following key instrument testing capabilities:

Thermo Fisher – QuantStudio 12K Flex
- COVID-19 testing
- Cannabis Testing
- Clinical Genomics
Roche Cobas 6000
- COVID-19 Antibody testing
- Clinical Chemistry/Endocrinology
AB SCIEX 6500+ – Liquid Chromatography Mass Spectrometry
- Clinical Chemistry/Endocrinology
- Agriculture/Cannabis testing
AB SCIEX 4500 – Liquid Chromatography Mass Spectrometry
- Urine Toxicology
- Cannabis testing
SYSMEX XN-550
- Hematology

USA COVID-19 Data as at August 31, 2020

TOTAL CASES: 5,972,356

TOTAL DEATHS: 182,622

CASES IN LAST 7 DAYS: 289,865

ARIZONA as at August 31, 2020

CONFIRMED CASES: 199,984

PROBABLE CASES: 1,713

TOTAL CASES: 201,661

CASES IN LAST 7 DAYS: 3,558

CASES/100K: 1,769

DEATHS/100K: 70

TEXAS as at August 31, 2020

TOTAL CASES: 610,354

CASES IN LAST 7 DAYS: 32,817

CASES/100K: 2,126

DEATHS/100K: 46

(COLA) is the premier clinical laboratory accreditation, education and consultation organization. An independent accreditor whose practical, educational standards have a positive and immediate impact on patient care. http://www.cola.org

The transaction is expected to be structured on a tax efficient basis, and otherwise in accordance with the requirements of requisite securities laws and the policies of the CSE. Empower has agreed to enter into employment agreements with Yoshi Tyler and Michael Haines, each having an initial term of two years.

Completion of the transaction will be subject to various conditions, including entry into a definitive agreement, completion of due diligence, and receipt of all required shareholder, manager, third party and regulatory approvals, including approval of the CSE. Closing of the transaction is expected to occur prior to October 15, 2020.

ABOUT EMPOWER

ABOUT KAI MEDICAL LABORATORY

Our mission is to change healthcare through science & innovative quality care by providing value added services, accuracy, and consistency. Our unwavering commitment to quality compliance and scientific innovation elevates Kai Medical Laboratory to a new standard in patient care. Kai Medical Laboratory is located in the Dallas Medical District in close proximity to some of the largest healthcare groups in the U.S. including Parkland Hospital, UT Southwestern, Children’s Medical Center, Baylor Scott & White Health (Dallas), Tenet Healthcare (Dallas), CHRISTUS Healthcare (Dallas).

ON BEHALF OF THE BOARD OF DIRECTORS:

Steven McAuley
Chief Executive Officer

CONTACTS:

Investors: Dustin Klein

Director
[email protected]
720-352-1398

Investors: Steven McAuley

CEO
[email protected]
604-789-2146

DISCLAIMER FOR FORWARD-LOOKING STATEMENTS

SOURCE: Empower Clinics Inc.

Tags: CBD, covid19, CSE, Dosed Movie, Dosed Wellness, Hemp, investments, Kai Medical Laboratory, small cap, small cap stocks, stocks, tsx
Posted in Empower Clinics Inc. | Comments Off on Empower Clinics $CBDT.ca Announces Acquisition of Medical Diagnostics Laboratory $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca

Datametrex $DM.ca Appoints New Chief Financial Officer

Posted by AGORACOM-JC at 7:57 PM on Monday, August 31st, 2020

Announced the appointment of Don Shim, CPA, CA as the new Chief Financial Officer
This new addition to the Company’s executive leadership team brings nearly 20 years of financial experience in accounting and financial control along with a combination of private and public companies in a variety of industries.

TORONTO, Aug. 31, 2020 — Datametrex AI Limited (“Datametrex” or the “Company“) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce the appointment of Don Shim, CPA, CA as the new Chief Financial Officer (“CFO”).

This new addition to the Company’s executive leadership team brings nearly 20 years of financial experience in accounting and financial control along with a combination of private and public companies in a variety of industries. These include cannabis, resource, and financial services. Don will work to ensure Datametrex’s financial health through strategic planning and management of the company’s finances.

Mr. Shim has led a successful accounting and finance career in both the US and Canada. He brings a wealth of knowledge to the team with his expertise in auditing publicly- traded junior mining companies and high-tech industries. Member of the Chartered Professional Accountants of British Columbia and a Certified Public Accountant registered in the State of Illinois, United States.
Audit partner on numerous audit engagements for various publicly traded companies, primarily focusing on junior mining, oil and gas, pharmaceutical, and high-tech industries.
Mr. Shim also assisted various start-up companies in achieving public listings on the TSX Venture Exchange, Canadian Securities Exchange and the OTC Market.
In addition, Mr. Shim teaches accounting at a local college in Vancouver and acts as a facilitator at CPA Western School of Business, mentoring CPA candidates enrolled in the CPA Professional Education Program.

“I am thrilled to join Datametrex and this impressive leadership team with a history of growing great companies, and I am happy to be a part of this enterprise,” said Don.

“On behalf of the executive team and our Board of Directors, I would like to thank Steve Kang for his dedication and hard work during his tenure as CFO. I wish Steve nothing but success in his future endeavours,” said Paul Haber, audit committee chair of the Company.

About Datametrex

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Forward-Looking Statements

Tags: covid19, CSE, datametrex, investments, Lotte, Lotte Home Shopping, PCL
Posted in Datametrex AI Limited | Comments Off on Datametrex $DM.ca Appoints New Chief Financial Officer

Posts Tagged ‘investments’

IoT and Big Data: 6 Retail and Financial Services Trends to Watch Out For

1. IoT Will Make Risk Assessment Seamless and Easy

2. IoT Will Enhance and Automate Security in Financial Institutions

3. IoT Will Revolutionize Point of Sale (POS) Payments

4. More Efficient Inventory Management

5. Smart Asset Movement and Monitoring

6. Increasing Use of Wearable Tech for Financial Transactions

Why AI and IoT will play a big role in retail of tomorrow

AI

IoT

Categories